In clinical trials, the impact of DUPIXENT on lung function was studied in patients 6 to 11 years of age and patients 12 years of age and older. Some patients in each age group saw improved lung function in as little as 2 weeks. Some adults felt their asthma symptoms improve in as little as 3 days.*

*This information is based on patients' morning symptom diaries in a post hoc analysis. The relationship between DUPIXENT and these results was studied but not definitively proven.

Learn how DUPIXENT helped treat children 6 to 11 years old with their moderate-to-severe asthma.